treatment of patients
tests
novel fast test
optimal antibiotic treatment
antibiotic susceptibility testing
antibiotic drug susceptibility
serious bacterial infections
susceptibility report
accurate AST testing
breakthrough test method
project
panels of antibiotics
line antibiotics
hours
consortium
novel flow cytometry-based test
Gram positive
turnaround time
useful time
major impact
great impact
software package
clinical validation
interpretation of results
dissemination plan
exploitation plan
Gram negative bacteria
microplate-based kit
health care costs
designed decision support software
order
quality of life
kits
difficulties
use of broad spectrum
case of blood cultures
regulatory proceedings
microbiology diagnostic laboratories
compatible probes
US standard methods
market launch
current methodology
convenient result delivery
technical file
effect
Europe
expansion
clinicians
Resistance
large-scale production
addition
products
opportunities
regions
commercialisation